OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy
Bayan Al-Share, Nour Hammad, Maria Diab
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 1, pp. 355-371
Closed Access | Times Cited: 9
Bayan Al-Share, Nour Hammad, Maria Diab
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 1, pp. 355-371
Closed Access | Times Cited: 9
Showing 9 citing articles:
Cystatin A promotes the antitumor activity of T helper type 1 cells and dendritic cells in murine models of pancreatic cancer
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, et al.
Molecular Oncology (2025)
Open Access
Alessandro Nasti, Shingo Inagaki, Tuyen Thuy Bich Ho, et al.
Molecular Oncology (2025)
Open Access
Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance
Enrique Rozengurt, Guido Eibl
Cancers (2021) Vol. 13, Iss. 20, pp. 5126-5126
Open Access | Times Cited: 23
Enrique Rozengurt, Guido Eibl
Cancers (2021) Vol. 13, Iss. 20, pp. 5126-5126
Open Access | Times Cited: 23
Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study
Ada Aita, Caterina Millino, Cosimo Sperti, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 845-845
Open Access | Times Cited: 11
Ada Aita, Caterina Millino, Cosimo Sperti, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 845-845
Open Access | Times Cited: 11
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
New Therapeutic Targets in RAS Wild-type Pancreatic Cancer
Maria Diab
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Maria Diab
Current Treatment Options in Oncology (2024)
Closed Access | Times Cited: 1
Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 652-652
Open Access | Times Cited: 7
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 652-652
Open Access | Times Cited: 7
The heterogeneity of CAFs and immune cell populations in the tumor microenvironment of pancreatic adenocarcinoma
Maria Diab, Bassel F. El‐Rayes
Journal of Cancer Metastasis and Treatment (2022) Vol. 8, pp. 42-42
Open Access | Times Cited: 5
Maria Diab, Bassel F. El‐Rayes
Journal of Cancer Metastasis and Treatment (2022) Vol. 8, pp. 42-42
Open Access | Times Cited: 5
Implications of cancer stem cells in diabetes and pancreatic cancer
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Life Sciences (2022) Vol. 312, pp. 121211-121211
Closed Access | Times Cited: 4
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, et al.
Life Sciences (2022) Vol. 312, pp. 121211-121211
Closed Access | Times Cited: 4
Metastasis Suppressor Genes in Pancreatic Cancer
Arnav Bhattacharya, Anirudh Santhoshkumar, Hiroshi Kurahara, et al.
Pancreas (2021) Vol. 50, Iss. 7, pp. 923-932
Closed Access | Times Cited: 3
Arnav Bhattacharya, Anirudh Santhoshkumar, Hiroshi Kurahara, et al.
Pancreas (2021) Vol. 50, Iss. 7, pp. 923-932
Closed Access | Times Cited: 3
